ATAC - Bone Density Sub-Protocol

NCT00784940 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Density

Interventions

DRUG: Anastrozole
DRUG: Tamoxifen

Sponsor

AstraZeneca